Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. [electronic resource]
Producer: 20011011Description: 457-63 p. digitalISSN:- 0022-5223
- Aged
- Aprotinin -- therapeutic use
- Aspirin -- adverse effects
- Blood Component Transfusion -- statistics & numerical data
- Combined Modality Therapy
- Coronary Artery Bypass -- adverse effects
- Coronary Disease -- drug therapy
- Double-Blind Method
- Drainage
- Female
- Hemoglobins -- analysis
- Hemostatics -- therapeutic use
- Humans
- Infusions, Intravenous
- Male
- Mediastinum
- Middle Aged
- Platelet Aggregation Inhibitors -- adverse effects
- Postoperative Care -- methods
- Postoperative Hemorrhage -- blood
- Prospective Studies
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.